Back to Catalog
Asimov
asimov
Mammalian synthetic biology platform combining CAD and AI for biologics and gene therapy manufacturing
Total Funding
$204.7M
sector:biotech
stage:series_b
synthetic_biology
cho_cell_line
biomanufacturing
gene-therapy
cad_for_biology
Full Profile Gated
Register as a Qualified Purchaser to access the full profile of Asimov, including financial analysis, competitive landscape, and investment thesis.